1
Schildgen V, van den Hoogen B, Fouchier R, Tripp RA, Alvarez R, Manoha C, et al. Human metapneumovirus: Lessons learned over the first decade. Clinical Microbiology Reviews. 2011;24(4):734–54.
2.
Kim J Il, Park S, Lee I, Park KS, Kwak EJ, Moon KM, et al. Genome-wide analysis of human metapneumovirus evolution. PLoS One. 2016;11(4):1–19.
3.
Edwards Kathryn M., Zhu Yuwei, Griffin Marie R., Weinberg Geoffrey A., Hall Caroline
B., Szilagyi Peter G., Staat Mary A., Iwane Marika PMM, V. WJ. Burden of Human Metapneumovirus Infection in Young Children. New England Journal of Medicine. 2013;368(7):633–43.
4.
Neto DF de L, Carraro E, Hern CF, Granato es, Bellei NCJ. Human metapneumovirus infections in adults associated with respiratory illness in
Sao Paulo, Brazil. Journal of Public Health and Epidemioly. 2013;5(6):257–61.
5.
van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, et al.
A newly discovered human pneumovirus isolated from young children with respiratory
tract disease. Nature Medicine. 2001;7(6):719–24.
6.
Panda S, Mohakud NK, Pena L, Kumar S. Human metapneumovirus: Review of an important respiratory pathogen. International Journal of Infectious Disease . 2014;25:45–52.
7.
Shafagati N, Williams J. Human metapneumovirus - what we know now. F1000Research. 2018;7:135.
8.
Van den Hoogen BG, van Doornum GJ, Fockens JC, Cornelissen JJ, Beyer WE, de Groot
R, et al. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized
patients. Journal of Infectious Disease. 2003;188(10):1571–7.
9.
Moe N, Krokstad S, Stenseng IH, Christensen A, Skanke LH, Risnes KR, et al. Comparing human metapneumovirus and respiratory syncytial virus: Viral codetections,
genotypes and risk factors for severe disease. PLoS One. 2017;12(1):1–19.
10.
Papenburg J, Hamelin M-È, Ouhoummane N, Carbonneau J, Ouakki M, Raymond F, et al.
Comparison of Risk Factors for Human Metapneumovirus and Respiratory Syncytial Virus
Disease Severity in Young Children. Journal of Infectious Disease. 2012;206(2):178–89.
11.
Hoogen BG Van Den, Herfst S, Sprong L, Cane PA, Forleo-neto E, Swart RL De, et al.
Antigenic and Genetic Variability of Human Metapneumoviruses. Emerging Infectious Diseases. 2004;10(4):658.
12.
Endo R, Ebihara T, Ishiguro N, Teramoto S, Ariga T, Sakata C, et al. Detection of four genetic subgroup-specific antibodies to human metapneumovirus attachment
(G) protein in human serum. Journal of General Virology. 2008;89(8):1970–7.
13.
Biacchesi S, Skiadopoulos MH, Boivin G, Hanson CT, Murphy BR, Collins PL, et al. Genetic diversity between human metapneumovirus subgroups. Virology. 2003;315(1):1–9.
14.
Huck B, Scharf G, Neumann-Haefelin D, Puppe W, Weigl J, Falcone V. Novel human metapneumovirus sublineage. Emerging Infectious Diseases. 2006;12(1):147–50.
15.
Jagušić M, Slović A, Ljubin-Sternak S, Mlinarić-Galinović G, Forčić D. Genetic diversity of human metapneumovirus in hospitalized children with acute respiratory
infections in Croatia. Journal of Medical Virology. 2017;89(11):1885–93.
16.
Rahman MZ, Sumiya M, Sahabuddin M, Pell LG, Gubbay JB, Rahman R, et al. Genetic characterization of human metapneumovirus identified through community and
facility-based surveillance of infants in Dhaka, Bangladesh. Journal of Medical Virology. 2019;91(4):549–54.
17.
M. S, C. K, N. N, M. T, S. U, T. S, et al. 180-nucleotide duplication in the G Gene of Human metapneumovirus A2b subgroup strains
circulating in Yokohama City, Japan, since 2014. Frontiers in Microbiology. 2017; 8:402
18.
Piñana M, Vila J, Gimferrer L, Valls M, Andrés C, Codina MG, et al. Novel human metapneumovirus with a 180-nucleotide duplication in the G gene. Future Microbiology. 2017;12(7):565–71.
19.
Reiche J, Jacobsen S, Neubauer K, Hafemann S, Nitsche A, Milde J, et al. Human metapneumovirus: Insights from a ten-year molecular and epidemiological analysis
in Germany. PLoS One. 2014;9(2).
20.
Presti A Lo, Cammarota R, Apostoli P, Cella E, Fiorentini S, Babakir-Mina M, et al.
Genetic variability and circulation pattern of human metapneumovirus isolated in Italy
over five epidemic seasons. New Microbiology. 2011;34(4):337–44.
21.
Chow WZ, Chan YF, Oong XY, Ng LJ, Nor’E SS, Ng KT, et al. Genetic diversity, seasonality and transmission network of human metapneumovirus:
Identification of a unique sub-lineage of the fusion and attachment genes. Scientific Reports. 2016;6(9):27730.
22.
Peret TCT, Hall CB, Hammond GW, Piedra PA, Storch GA, Sullender WM, et al. Circulation Patterns of Group A and B Human Respiratory Syncytial Virus Genotypes
in 5 Communities in North America. Journal of Infectious Disease .2000;181(6):1891–6.
23.
Peret TC, Golub JA, Anderson LJ, Hall CB, Schnabel KC. Circulation patterns of genetically distinct group A and B strains of human respiratory
syncytial virus in a community. Journal of General Virology . 1998;79(9):2221–9.
24.
Maggi F, Pifferi M, Vatteroni M, Fornai C, Tempestini E, Anzilotti S, et al. Human metapneumovirus associated with respiratory tract infections in a 3-year study
of nasal swabs from infants in Italy. Journal of Clinical Microbiology. 2003;41(7):2987–91.
25.
Rafiefard F, Yun ZB, Örvell C. Epidemiologic characteristics and seasonal distribution of human metapneumovirus infections
in five epidemic seasons in Stockholm, Sweden, 2002-2006. Journal of Medical Virology. 2008;80(9):161-8.
26.
Green RJ, Kolberg JM. Neonatal pneumonia in sub-Saharan Africa. Pneumonia . 2016;0–1.
27.
Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: An updated systematic analysis
for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151–61.
28.
Owor BE, Masankwa GN, Mwango LC, Njeru RW, Agoti CN, Nokes DJ. Human metapneumovirus epidemiological and evolutionary patterns in Coastal Kenya,
2007-11. BMC Infectious Diseases. 2016;16(1):301.
29.
Nokes DJ, Ngama M, Bett A, Abwao J, Munywoki P, English M, et al. Incidence and Severity of Respiratory Syncytial Virus Pneumonia in Rural Kenyan Children
Identified through Hospital Surveillance. Clinical Infectious Diseases. 2009; 49(9):1341-9.
30.
Scott JAG, Bauni E, Moisi JC, Ojal J, Gatakaa H, Nyundo C, et al. Profile : The Kilifi Health and Demographic Surveillance System ( KHDSS ).International Journal of Epidemiology 2012;(April): 41(3):650-7.
31.
Berkley J a, Munywoki P, Ngama M, Abwao J, Bett A, Lassauniére R, et al. Viral etiology of severe pneumonia among Kenyan young infants and children. Jama. 2010;303(20):2051–7.
32.
Hammitt LL, Kazungu S, Welch S, Bett A, Onyango CO, Gunson RN, et al. Added value of an oropharyngeal swab in detection of viruses in children hospitalized
with lower respiratory tract infection. Journal of Clinical Microbiology. 2011;49(6):2318–20.
33.
Rosenblum BB, Lee LG, Spurgeon SL, Khan SH, Menchen SM, Heiner CR, et al. New dye-labeled terminators for improved DNA sequencing patterns. Nucleic acids Research. 1997;25(22):4500–4.
34.
Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: Improvements in performance
and usability. Molecular Biology and Evolution. 2013;30(4):772–80.
35.
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary
distance, and maximum parsimony methods. Molecular Biology and Evolution. 2011;28(10):2731–9.
36.
Graaf M De, Osterhaus ADME, Fouchier RAM, Holmes EC. Evolutionary dynamics of human and avian metapneumoviruses. Journal of General Virology 2018;(2008):2933–42.
37.
Yang Z, Swanson WJ. Codon-substitution models to detect adaptive evolution that account for heterogeneous
selective pressures among site classes. Molecular Biology and Evolution. 2002;19(1):49–57.
38.
Yang Z. PAML 4: Phylogenetic analysis by maximum likelihood. Molecular Biology and Evolution. 2007;24(8):1586–91.
39.
World Health Organization (WHO). Acute respiratory infections in children: case management in small hospitals in developing
countries, a manual for doctors and other senior health workers. Geneva: World Health Organisation; 1990. p. 76.
40.
Vicente D, Montes M, Cilla G, Perez-yarza EG, Perez-trallero E. Differences in Clinical Severity between Genotype A and Genotype B Human Metapneumovirus
Infection in Children. Clinical Infectious Diseases. 2006;42(March):111–3.
41.
Saikusa M, Kawakami C, Nao N, Takeda M, Usuku S, Sasao T, et al. 180-nucleotide duplication in the G Gene of Human metapneumovirus A2b subgroup strains
circulating in Yokohama City, Japan, since 2014. Frontiers Microbiology. 2017;8(March):1–11.
42.
Nidaira M, Taira K, Hamabata H, Kawaki T, Gushi K, Mahoe Y, et al. Molecular epidemiology of human metapneumovirus from 2009 to 2011 in Okinawa, Japan. Japanese Journal of Infectious Diseases. 2012; 65(4):337-40.
43.
Pitoiset C, Darniot M, Huet F, Aho S, Manoha C. Human metapneumovirus genotypes and severity of disease in young children (n= 100)
during a 7-year study in Dijon ,Journal of Medical Virology. 2010;82(10):1782-9.
44.
Yang C-F, Wang CK, Tollefson SJ, Piyaratna R, Lintao LD, Chu M, et al. Genetic diversity and evolution of human metapneumovirus fusion protein over twenty
years. Virology Journal. 2009;6(1):138.
45.
Li J, Ren L, Guo L, Xiang Z, Paranhos-Baccalà G, Vernet G, et al. Evolutionary dynamics analysis of human metapneumovirus subtype A2: Genetic evidence
for its dominant epidemic. PLoS One. 2012;7(3):1–9.
46.
Padhi A, Verghese B. Positive natural selection in the evolution of human metapneumovirus attachment glycoprotein. Virus Research. 2008;131(2):121–31.
47.
Peret TC, Abed Y, Anderson LJ, Erdman DD, Boivin G. Sequence polymorphism of the predicted human metapneumovirus G glycoprotein. Journal of general virology. 2004 Mar 1;85(3):679-86.
48
Ngama M, Bett A, Cane PA, Medley GF, Nokes DJ, Gitahi CW, et al. Molecular Evolutionary Dynamics of Respiratory Syncytial Virus Group A in Recurrent
Epidemics in Coastal Kenya. Journal of Virology. 2016;90(10):4990–5002.
49.
Zlateva KT, Lemey P, Vandamme AM, Van Ranst M. Molecular evolution and circulation patterns of human respiratory syncytial virus
subgroup A: positively selected sites in the attachment G glycoprotein. Journal of virology. 2004 May 1;78(9):4675-83.
50.
Skiadopoulos MH, Biacchesi S, Buchholz UJ, Riggs JM, Surman SR, Amaro-Carambot E,
McAuliffe JM, Elkins WR, Claire MS, Collins PL, Murphy BR. The two major human metapneumovirus genetic lineages are highly related antigenically,
and the fusion (F) protein is a major contributor to this antigenic relatedness. Journal of Virology. 2004 Jul 1;78(13):6927-37
51.
Gunson RN, Collins TC, Carman WF. Practical experience of high throughput real time PCR in the routine diagnostic virology
setting. Journal of Clinical Virology. 2006; (Apr) 1;35(4):355-67
52.
Kamau E, Agoti CN, Lewa CS, Oketch J, Owor BE, Otieno GP, et al. Recent sequence variation in probe binding site affected detection of respiratory
syncytial virus group B by real-time RT-PCR. Journal of Clinical Virology. 2017;88:21–5.
53.
Silaba M, Ooko M, Bottomley C, Sande J, Benamore R, Park K, et al. Articles Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed
pneumonia and clinically-defined pneumonia in Kenyan children : an interrupted time-series analysis. Lancet Global Health. 2019;7(3):e337–46.
54.
Madhi SA, Klugman KP. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nature Medicine. 2004;10(8):811–3.
55.
Fathima P, Blyth CC, Lehmann D, Lim FJ, Abdalla T, De Klerk N, et al. The Impact of Pneumococcal Vaccination on Bacterial and Viral Pneumonia in Western
Australian Children: Record Linkage Cohort Study of 469589 Births, 1996-2012. Clinical Infectious Disease. 2018;66(7):1075–85.
56.
Hughes AL, Hughes MA. More effective Purifying selection on RNA viruses than in DNA viruses. Gene. 2007 Dec 1;404(1-2):117-25.
57.
Nyiro JU, Munywoki P, Kamau E, Agoti C, Gichuki A, Etyang T, et al. Surveillance of respiratory viruses in the outpatient setting in rural coastal Kenya:
baseline epidemiological observations. Wellcome Open Research. 2018; 3.